Literature DB >> 9733833

Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.

C T Wang1, H Y Lai, J J Li.   

Abstract

We have constructed a series of human immunodeficiency virus (HIV) gag mutants by progressive truncation of the gag coding sequence from the C terminus and have combined these mutants with an assembly-competent matrix domain deletion mutation (DeltaMA). By using several methods, the particle-producing capabilities of each mutant were examined. Our analysis indicated that truncated Gag precursors lacking most of C-terminal gag gene products assembled and were released from 293T cells. Additionally, a mutant with a combined deletion of the MA (DeltaMA) and p6 domains even produced particles at levels comparable to that of the wild-type (wt) virus. However, most mutants derived from combination of the DeltaMA and the C-terminal truncation mutations did not release particles as well as the wt. Our smallest HIV gag gene product capable of virus-like particle formation was a 28-kDa protein which consists of a few MA amino acids and the CA-p2 domain. Sucrose density gradient fractionation analysis indicated that most mutants exhibited a wt retrovirus particle density. Exceptions to this rule were mutants with an intact MA domain but deleted downstream of the p2 domains. These C-terminal truncation mutants possessed particle densities of 1.13 to 1.15 g/ml, lower than that of the wt. The N-terminal portions of the CA domain, which have been shown to be dispensable for core assembly, became critical when most of the MA domain was deleted, suggesting a requirement for an intact CA domain to assemble and release particles.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733833      PMCID: PMC110128     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.

Authors:  X Yu; X Yuan; Z Matsuda; T H Lee; M Essex
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Form, function, and use of retroviral gag proteins.

Authors:  J W Wills; R C Craven
Journal:  AIDS       Date:  1991-06       Impact factor: 4.177

3.  Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles.

Authors:  A J Smith; N Srinivasakumar; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

4.  Expression and extracellular release of human immunodeficiency virus type 1 Gag precursors by recombinant baculovirus-infected cells.

Authors:  M Royer; S S Hong; B Gay; M Cerutti; P Boulanger
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

5.  Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro.

Authors:  L S Ehrlich; B E Agresta; C A Carter
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

6.  The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.

Authors:  J Park; C D Morrow
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

7.  Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis.

Authors:  C Strambio-de-Castillia; E Hunter
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  Mutations in the gag gene of Moloney murine leukemia virus: effects on production of virions and reverse transcriptase.

Authors:  P Schwartzberg; J Colicelli; M L Gordon; S P Goff
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

9.  Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation.

Authors:  J B Jowett; D J Hockley; M V Nermut; I M Jones
Journal:  J Gen Virol       Date:  1992-12       Impact factor: 3.891

10.  Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins.

Authors:  R P Bennett; T D Nelle; J W Wills
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more
  30 in total

1.  RNA incorporation is critical for retroviral particle integrity after cell membrane assembly of Gag complexes.

Authors:  Shainn-Wei Wang; Anna Aldovini
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Nucleocapsid-RNA interactions are essential to structural stability but not to assembly of retroviruses.

Authors:  Shainn-Wei Wang; Kristin Noonan; Anna Aldovini
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

3.  Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly.

Authors:  Y Morikawa; D J Hockley; M V Nermut; I M Jones
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Assembly and processing of human immunodeficiency virus Gag mutants containing a partial replacement of the matrix domain by the viral protease domain.

Authors:  C T Wang; Y C Chou; C C Chiang
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

5.  Quantitative fluorescence resonance energy transfer microscopy analysis of the human immunodeficiency virus type 1 Gag-Gag interaction: relative contributions of the CA and NC domains and membrane binding.

Authors:  Ian B Hogue; Adam Hoppe; Akira Ono
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

6.  Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.

Authors:  M A Accola; B Strack; H G Göttlinger
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

7.  Second site reversion of a mutation near the amino terminus of the HIV-1 capsid protein.

Authors:  Claudia S López; Seyram M Tsagli; Rachel Sloan; Jacob Eccles; Eric Barklis
Journal:  Virology       Date:  2013-09-21       Impact factor: 3.616

8.  The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release.

Authors:  Daniel Melamed; Michal Mark-Danieli; Michal Kenan-Eichler; Osnat Kraus; Asher Castiel; Nihay Laham; Tal Pupko; Fabian Glaser; Nir Ben-Tal; Eran Bacharach
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Analysis of the initiating events in HIV-1 particle assembly and genome packaging.

Authors:  Sebla B Kutluay; Paul D Bieniasz
Journal:  PLoS Pathog       Date:  2010-11-18       Impact factor: 6.823

Review 10.  Roles played by acidic lipids in HIV-1 Gag membrane binding.

Authors:  Balaji Olety; Akira Ono
Journal:  Virus Res       Date:  2014-07-03       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.